Family Med

Your Article Summary

See Latest Articles

Prescribing statins to patients with nonalcoholic fatty liver disease: Real cardiovascular benefits outweigh theoretical hepatotoxic risk
Cardiovascular Drug Reviews, 06/26/09

Riley P et al. – A review summarizes the evidence for and against the prescription of statins to pts with nonalcoholic fatty liver disease, a group typically associated with high cardiovascular risk.

• Review of evidence for/against statin use in nonalcoholic fatty liver disease

• Statins are widely prescribed, with a significant role in reducing cardiovascular risk
• Concern for hepatic safety profile may prevent use for pts with concurrent liver pathology
• Contrary to current opinion, considerable evidence for and little evidence against prescription of statins to this population
• Guidelines advising against statin use in this setting should be reviewed

Today in Atherosclerosis/Lipids...keeping you current

Receive free subspecialty "5-minute updates" via email

Biphasic effects of hormone treatment on risk of cardiovascular disease
Sexuality, Reproduction & Menopause, 10/20/09

Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A2 mass in statin-treated subjects with hypertriglyceridemia
Journal of Clinical Lipidology, 10/14/09

Prevalence of Unresponsiveness to Aspirin and/or Clopidogrel in Patients With Stable Coronary Heart Disease
The American Journal of Cardiology, 10/21/09

See All of Atherosclerosis/Lipids